国产热热热精品,亚洲视频久久】日韩,三级婷婷在线久久,99人妻精品视频,精品九热人人肉肉在线,AV东京热一区二区,91po在线视频观看,久久激情宗合,青青草黄色手机视频

  Home>News Center>China
       
 

Roche licenses China firm to produce Tamiflu
(AP/Xinhua)
Updated: 2005-12-12 19:57

Roche has come under international pressure to ease its monopoly grip on the manufacture of Tamiflu, which is considered the most efficient treatment in case of an outbreak of human influenza caused by a mutation of the bird flu virus.

The company has been pressed to step up production, cut prices and allow other companies to make copies of the drug.

Roche said it will now evaluate the potential partners' specific skills, the quality of their production and their delivery speed before making the final choice. "We will then choose among the companies to help us with certain steps in the production process such as fermentation or alcoholic granulation," said Roche spokesman Daniel Piller.

Roche has pledged to increase the production of Tamiflu by nearly six-fold by planning to make 300 million treatments annually by 2007 in order to meet government orders amid fears of a flu pandemic.

Roche said it could already produce the 300 million annual treatments with its existing partners such as Mylan Laboratories Inc. of Pittsburgh or Israeli drugmaker Teva Pharmaceutical Industries. The making of Tamiflu is considered very complicated.

Although some 50 companies around the world have bought or ordered supplies of Tamiflu for pandemic stockpiles, so far Roche has no firm orders for 2007. That leaves the company with a large degree of uncertainty over possible future needs.

For example, Roche has not yet received any large orders from the United States — although President Bush has proposed stockpiling anti-flu drugs Tamiflu and GlaxoSmithKline PLC's Relenza for 81 million people. and U.S. Department of Health and Human Services Secretary Michael Leavitt has called for a Tamiflu stockpile to treat 20 million Americans. So far, the United States has only enough anti-flu drug doses in stock to treat 4.3 million people.

Roche said it has already brought forward delivery schedules for countries that have had large bird-flu outbreaks, or are near countries that have. Roche has also allowed Vietnamese companies to encapsulate Tamiflu locally.

Tamiflu is not patent-protected in Thailand, the Philippines and Indonesia. As a result, local governments can purchase and manufacture oseltamimivir at their discretion.

Roche shares fell 0.2 percent to 204.70 Swiss francs ($157.20) in Zurich trading.

   上一頁(yè) 1 2 下一頁(yè)  



Fire kills 5 in Northeast China
Aerobatics show in Hunan
Final rehearsal
  Today's Top News     Top China News
 

Australia, US, Japan praise China for Asia engagement

 

   
 

Banker: China doing its best on flexible yuan

 

   
 

Hopes high for oil pipeline deal

 

   
 

Possibilities of bird flu outbreaks reduced

 

   
 

Milosevic buried after emotional farewell

 

   
 

China considers trade contracts in India

 

   
  EU likely to impose tax on imports of Chinese shoes
   
  Bankers confident about future growth
   
  Curtain to be raised on Year of Russia
   
  Coal output set to reach record high of 2.5b tons
   
  WTO: China should reconsider currency plan
   
  China: Military buildup 'transparent'
   
 
  Go to Another Section  
 
 
  Story Tools  
   
  Related Stories  
   
Roche sets up R&D centre in Shanghai
   
Roche to expand presence in China
   
China human bird flu vaccine at least a year away
   
China: Bird flu virus in humans mutating
   
Study: Vaccine can stop poultry from spreading bird flu to each other
   
China confirms fifth human case of bird flu
   
Human case confirmed in Liaoning
   
Roche in talks for Tamiflu production in China
Manufacturers, Exporters, Wholesalers - Global trade starts here.
Advertisement
         
长岭县| 德昌县| 穆棱市| 大同市| 广河县| 隆安县| 武乡县| 拜城县| 吉水县| 桃园县| 博白县| 黎城县| 长沙县| 出国| 广水市| 秀山| 汶上县| 左贡县| 安达市| 隆回县| 阿尔山市| 佛山市| 宽甸| 青田县| 灵宝市| 大理市| 沁源县| 镇平县| 双峰县| 瓮安县| 刚察县| 司法| 平陆县| 延吉市| 兴国县| 增城市| 越西县| 正安县| 绿春县| 武威市| 西吉县|